Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hay

Showing results (551-560 of 653) with videos related to

Pageof 66
Sort By:
The Journal of Biological Chemistry|March 26, 2016
Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular PropertiesHarriet A Watkins, Madhuri Chakravarthy, Rekhati S Abhayawardana, et al.
JAMA Dermatology|November 9, 2017
Interdisciplinary Perspectives on Sun SafetyAlan C Geller, Nina G Jablonski, Sherry L Pagoto, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 28, 2017
Commentary on the MID3 Good Practices PaperEfthymios Manolis, Jacob Brogren, Susan Cole, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 2, 2017
Patient perspectives on ipilimumab across the melanoma treatment trajectoryElyse Shuk, Alexander N Shoushtari, Jason Luke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 11, 2009
Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest GroupMarc T Kiviniemi, Jennifer L Hay, Aimee S James, et al.
BMJ Open|November 5, 2017
Protocol for the HAPPY Hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort studyKevin F Boreskie, D Scott Kehler, Eduardo C Costa, et al.
Journal of Cancer Research and Clinical Oncology|December 7, 2016
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanomaThomas M Atkinson, Jennifer L Hay, Alexander Shoushtari, et al.
NPJ Vaccines|April 2, 2026
Cattle antibodies identify a cross-serotype broadly neutralising foot-and-mouth disease virus epitopeMarie Bonnet-Di Placido, Helen M E Duyvesteyn, Angela W Steyn, et al.
Cancer|October 4, 2018
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trialsJoanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.
British Journal of Pharmacology|September 16, 2021
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptorsStephen Ph Alexander, Arthur Christopoulos, Anthony P Davenport, et al.
Pageof 66

Showing results (551-560 of 653) with videos related to

Sort By:
Pageof 66
The Journal of Biological Chemistry|March 26, 2016
Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular PropertiesHarriet A Watkins, Madhuri Chakravarthy, Rekhati S Abhayawardana, et al.
JAMA Dermatology|November 9, 2017
Interdisciplinary Perspectives on Sun SafetyAlan C Geller, Nina G Jablonski, Sherry L Pagoto, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 28, 2017
Commentary on the MID3 Good Practices PaperEfthymios Manolis, Jacob Brogren, Susan Cole, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 2, 2017
Patient perspectives on ipilimumab across the melanoma treatment trajectoryElyse Shuk, Alexander N Shoushtari, Jason Luke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 11, 2009
Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest GroupMarc T Kiviniemi, Jennifer L Hay, Aimee S James, et al.
BMJ Open|November 5, 2017
Protocol for the HAPPY Hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort studyKevin F Boreskie, D Scott Kehler, Eduardo C Costa, et al.
Journal of Cancer Research and Clinical Oncology|December 7, 2016
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanomaThomas M Atkinson, Jennifer L Hay, Alexander Shoushtari, et al.
NPJ Vaccines|April 2, 2026
Cattle antibodies identify a cross-serotype broadly neutralising foot-and-mouth disease virus epitopeMarie Bonnet-Di Placido, Helen M E Duyvesteyn, Angela W Steyn, et al.
Cancer|October 4, 2018
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trialsJoanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.
British Journal of Pharmacology|September 16, 2021
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptorsStephen Ph Alexander, Arthur Christopoulos, Anthony P Davenport, et al.
Pageof 66